UC Davis Cancer Center researchers have discovered a molecule called LXY1 that targets glioblastoma, a highly deadly form of brain cancer. Kit Lam, senior author of the study and UC Davis chief of hematology and oncology, made the discovery with his colleagues while searching for a molecule that could be injected into a patient's bloodstream and deliver high concentrations of medication or radionuclides directly to brain tumor cells while sparing normal tissues. The team's finding, published in the January 2009 issue of the European Journal of Nuclear Medicine and Molecular Imaging, offers hope for an effective treatment for a presently incurable cancer.